Physician profile
Jose Jacob
NPI 1194771832
$15,465.05
in general payments reported to CMS, 2019-2025
31 companies · $685 in 2025
The $685 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,329 · 2020: $1,682 · 2021: $693 · 2022: $3,091 · 2023: $1,421 · 2024: $4,565 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,800 · Travel and Lodging: $2,870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,800.44 |
| Travel and Lodging | $2,870.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,277.96 | 2020-2025 | Aveir, Merlin@Home, Jot Dx |
| Biotronik INC. | $3,930.51 | 2019-2025 | Biomonitor, Amvia Edge, Acticor 7 Vr-T Dx |
| Amgen INC. | $991.78 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $875.91 | 2019-2024 | Emblem Mri S-Icd, Sq-Rx Pulse Generator, Vigilant X4 Crt-D |
| Astrazeneca Pharmaceuticals LP | $723.90 | 2019-2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $610.51 | 2019-2025 | Lifevest |
| Novo Nordisk INC | $529.85 | 2019-2024 | Wegovy |
| Kestra Medical Technology Services, INC. | $363.70 | 2023-2024 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $312.79 | 2019-2024 | |
| Medtronic Vascular, INC. | $292.28 | 2019-2020 | |
| Vifor Pharma, INC. | $200.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $192.77 | 2019-2020 | |
| Amarin Pharma, INC. | $169.95 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $165.85 | 2022 | |
| Medtronic, INC. | $153.13 | 2021-2023 | Amplia Mri Quad Crt-D Surescan |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $149.31 | 2022-2025 | |
| Cvrx, INC. | $84.45 | 2022 | |
| Atricure, INC. | $83.03 | 2023-2024 | |
| Elutia, INC. | $72.83 | 2019 | |
| Janssen Pharmaceuticals, INC | $55.18 | 2019-2021 | |
| Cardiovascular Systems INC. | $29.01 | 2022-2023 | Diamondback Coronary |
| Irhythm Technologies, INC. | $27.05 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.16 | 2025 | |
| Philips North America LLC | $23.09 | 2024 | (Ck4) Mcot |
| Merck Sharp & Dohme LLC | $22.70 | 2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $20.08 | 2019 | |
| Esperion Therapeutics, INC. | $19.85 | 2021 | |
| Inspire Medical Systems, INC. | $17.40 | 2025 | Inspire |
| Bard Peripheral Vascular, INC. | $17.20 | 2021 | |
| Itamar Medical INC | $17.00 | 2022 | |
| Arbor Pharmaceuticals, INC. | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.